DRSPLUS视网膜成像仪在糖尿病患者中的应用:共识分级、阅片中心与人工智能的比较研究
前瞻性横断面观察研究纳入224例糖尿病患者共422只眼、844张非散瞳视网膜图像,比较共识分级、阅片中心与人工智能系统的可分级率及糖尿病视网膜病变严重程度评估。图像水平可分级率分别为87.4%、97.4%、96.9%,眼水平分别为81.3%、97.4%、95.0%;人工智能检测需转诊糖尿病视网膜病变的敏感度为97.3%、特异度为80.4%、准确率为86.6%。
要点
- DRSplus在非散瞳条件下可对超过80%的眼完成视网膜成像。
- 阅片中心与人工智能的眼水平可分级率均高于共识分级。
- 人工智能检测需转诊糖尿病视网膜病变的敏感度为97.3%。
核心结论
- DRSplus视网膜成像仪可在非散瞳条件下对超过80%的眼完成视网膜成像,阅片中心与人工智能的可分级率高于共识分级。
- 人工智能系统对需转诊病例的评估显示高敏感度,提示基于远程医疗的工具用于糖尿病视网膜病变筛查的潜力。
研究设计与样本
- 前瞻性、横断面、观察性研究。
- 纳入224例糖尿病患者共422只眼、844张非散瞳重叠视网膜图像,比较共识分级、阅片中心与人工智能系统在图像水平和眼水平的可分级率。
- 糖尿病视网膜病变严重程度由阅片中心和人工智能分别分级。
主要发现
- 图像水平可分级率:共识分级87.4%、阅片中心97.4%、人工智能96.9%。
- 眼水平可分级率:共识分级81.3%、阅片中心97.4%、人工智能95.0%。
- 人工智能检测需转诊糖尿病视网膜病变的敏感度为97.3%、特异度为80.4%、准确率为86.6%。
临床怎么用
- 原文结论指出DRSplus可在非散瞳条件下对超过80%的眼完成视网膜成像,人工智能系统对需转诊病例显示高敏感度,提示基于远程医疗的工具用于糖尿病视网膜病变筛查的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the gradable rate of the retinal images acquired with DRSplus retinographer in patients with diabetes and to estimate the diabetic retinopathy (DR) severity, comparing different methods of analysis and grading. METHODS: Prospective, cross-sectional, observational study. A mosaic of overlapped retinal images in nonmydriatic condition was acquired, evaluating the gradable images rate at both image and eye-levels, from the human-study team (consensus grading), Reading Center, and an Artificial Intelligence (AI) system, respectively. The DR severity was graded by the Reading Center and the AI. RESULTS: A total of 844 images of 422 eyes from 224 patients were included. The gradable rate was 87.4%, 97.4%, and 96.9% at image-level and was 81.3%, 97.4%, and 95.0% at eye-level, according to the consensus grading, the Reading Center, and the AI, respectively. Artificial intelligence sensitivity for detecting referable DR was 97.3%, the specificity was 80.4%, and the accuracy was 86.6%. CONCLUSION: DRSplus retinographer allowed to image the retina in nonmydriatic condition in more than 80% of eyes, with a higher gradable rate with Reading Center and AI in comparison with consensus grading. The estimation of the DR severity showed a high sensitivity for referral cases for AI system, indicating the potentialities of telemedicine-based tool for the DR screening.
引用
- Parravano M, Costanzo E, De Geronimo D, et al. DRSPLUS RETINOGRAPHER IN PATIENTS WITH DIABETES: A Comparison Study by Consensus Grading, Reading Center, and Artificial Intelligence. Retina. 2026. PMID: 41248228. doi:10.1097/IAE.0000000000004734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。